EDA-FN is an alternatively spliced isoform of fibronectin that is selectively expressed in cancer-associated fibroblasts and tumor stroma, where it promotes extracellular matrix remodeling, tumor invasion, and immune evasion. The gene discussed is FN1; the disease is cancer.